Year in Review: Bay Area fed its drug habit with FDA approvals

No blockbusters, but the Bay Area's drug-development engine continued to produce a wide range of therapeutics in 2021. From a drug-implant developed by Genentech Inc. of South San Francisco for people with the eye disease wet age-related macular degeneration to San Mateo-based Myovant Sciences Ltd.'s treatment for women...

Click to view original post